Mohammad hojjat-farsangi

Mohammad hojjat-farsangi

Karolinska Institutet

H-index: 37

Europe-Sweden

About Mohammad hojjat-farsangi

Mohammad hojjat-farsangi, With an exceptional h-index of 37 and a recent h-index of 33 (since 2020), a distinguished researcher at Karolinska Institutet, specializes in the field of Targeted cancer therapy.

His recent articles reflect a diverse array of research interests and contributions to the field:

The sensitivity of acute myeloid leukemia cells to cytarabine is increased by suppressing the expression of Heme oxygenase-1 and Hypoxia-inducible factor 1-alpha

The role of exhausted natural killer cells in the immunopathogenesis and treatment of leukemia

Retraction Note: Dual Blockade of PD-1 and LAG3 Immune Checkpoints Increases Dendritic Cell Vaccine Mediated T Cell Responses in Breast Cancer Model

Silencing interleukin-6 and glycoprotein 130 suppresses growth and induces apoptosis in cancer cells

Detection of receptor tyrosine kinase-orphan receptor-2 using an electrochemical immunosensor modified with electrospun nanofibers comprising polyvinylpyrrolidone, soy, and …

The role of SF3B1 and NOTCH1 in the pathogenesis of leukemia

Corrigendum to" Silencing adenosine A2a receptor enhances dendritic cell-based cancer immunotherapy"[Nanomedicine Nanotechnol Biol Med 29 (2020) 102240]

Codelivery of Nrf 2 siRNA and Cyclophosphamide Inhibits Leukemia Progression

Mohammad hojjat-farsangi Information

University

Position

Karolinska university Hospital Solna

Citations(all)

4814

Citations(since 2020)

3625

Cited By

2470

hIndex(all)

37

hIndex(since 2020)

33

i10Index(all)

90

i10Index(since 2020)

77

Email

University Profile Page

Karolinska Institutet

Google Scholar

View Google Scholar Profile

Mohammad hojjat-farsangi Skills & Research Interests

Targeted cancer therapy

Top articles of Mohammad hojjat-farsangi

Title

Journal

Author(s)

Publication Date

The sensitivity of acute myeloid leukemia cells to cytarabine is increased by suppressing the expression of Heme oxygenase-1 and Hypoxia-inducible factor 1-alpha

Mohammad Sadeghi

Asma Moslehi

Hadiseh Kheiry

Fariba Karoon Kiani

Atefeh Khodakarami

...

2024/1/31

The role of exhausted natural killer cells in the immunopathogenesis and treatment of leukemia

Asal Barshidi

Keivan Ardeshiri

Farbod Ebrahimi

Fatemeh Alian

Ali Akbar Shekarchi

...

2024/1/22

Retraction Note: Dual Blockade of PD-1 and LAG3 Immune Checkpoints Increases Dendritic Cell Vaccine Mediated T Cell Responses in Breast Cancer Model

Pharmaceutical research

Asal Barshidi

Vahid Karpisheh

Fatemeh Karimian Noukabadi

Fariba Karoon Kiani

Mohammad Mohammadi

...

2024/2

Silencing interleukin-6 and glycoprotein 130 suppresses growth and induces apoptosis in cancer cells

International Journal of Drug Research in Clinics

Parastoo Khodayari

Atefeh Khodakarami

Hadi Hassannia

Ghasem Ghalamfarsa

Mohammad Hojjat-Farsangi

...

2023/5/17

Detection of receptor tyrosine kinase-orphan receptor-2 using an electrochemical immunosensor modified with electrospun nanofibers comprising polyvinylpyrrolidone, soy, and …

Microchimica Acta

Fatemeh Maleki

Habib Razmi

Mohammad-Reza Rashidi

Mehdi Yousefi

Soghra Ramazani

...

2023/10

The role of SF3B1 and NOTCH1 in the pathogenesis of leukemia

Shiva Abolhasani

Seyyed Sina Hejazian

Vahid Karpisheh

Atefeh Khodakarami

Hamed Mohammadi

...

2023/3

Corrigendum to" Silencing adenosine A2a receptor enhances dendritic cell-based cancer immunotherapy"[Nanomedicine Nanotechnol Biol Med 29 (2020) 102240]

Nanomedicine: nanotechnology, biology, and medicine

Ali Masjedi

Armin Ahmadi

Sepideh Ghanee

Farinaz Malakotikhah

Mohsen Nabi Afjadi

...

2023/5/9

Codelivery of Nrf 2 siRNA and Cyclophosphamide Inhibits Leukemia Progression

Atefeh Khodakarami

Mahsa Afsari Kashani

Atefeh Nazer

Armin Mahmoudsalehi Kheshti

Bentolhoda Rashidi

...

2023/8/2

Blockade of CD155 and interleukin-6 suppresses breast cancer cell growth

International Journal

Atefeh Khodakarami

Samira Darvishi

Hadi Hassannia

Mohammad Sadeghi

Sana Esmaeeli

...

2023

A small molecule targeting the intracellular tyrosine kinase domain of ROR1 (KAN0441571C) induced significant apoptosis of non-small cell lung cancer (NSCLC) Cells

Pharmaceutics

Amineh Ghaderi

Mohammad-Ali Okhovat

Jemina Lehto

Luigi De Petris

Ehsan Manouchehri Doulabi

...

2023/4/5

Targeted Silencing of NRF2 by rituximab-conjugated nanoparticles increases the sensitivity of chronic lymphoblastic leukemia cells to Cyclophosphamide

Cell Communication and Signaling

Atefeh Khodakarami

Mahsa Afsari Kashani

Atefeh Nazer

Armin Mahmoudsalehi Kheshti

Bentolhoda Rashidi

...

2023/8/1

Dual Blockade of PD-1 and LAG3 Immune Checkpoints Increases Dendritic Cell Vaccine Mediated T Cell Responses in Breast Cancer Model (Retraction of Vol 39, Pg 1851, 2022)

Pharmaceutical research

Asal Barshidi

Vahid Karpisheh

Fatemeh Karimian Noukabadi

Fariba Karoon Kiani

Mohammad Mohammadi

...

2022/8

Preeclampsia-derived exosomes imbalance the activity of Th17 and Treg in PBMCs from healthy pregnant women

Reproductive Sciences

Ramin Pourakbari

Forough Parhizkar

Mohammad Sadegh Soltani‐Zangbar

Parisa Samadi

Majid Zamani

...

2023/4

Evaluation of the anti-tumor effects of an anti-Human Epidermal growth factor receptor 2 (HER2) monoclonal antibody in combination with CD11b+/Gr-1+ myeloid cells depletion …

International Immunopharmacology

Khadijeh Ramezani-Aliakbari

Vahid Khaki-Bakhtiarvand

Jafar Mahmoudian

Hossein Asgarian-Omran

Fazel Shokri

...

2023/8/1

A CX3CR1 (fractalkine receptor) Small Molecular Antagonist (KAND567) Suppressed the Growth Promoting Effect of Monocytes on Chronic Lymphocytic Leukemia Cells

Blood

Mohammad Hojjat-Farsangi

Wen Zhong

Tom Mulder

Ann Svensson

Jeanette Lundin

...

2023/11/28

Pan Cyclin-Dependent Kinase Inhibitors for the Treatment of Breast Cancer

Sepideh Izadi

Mohammad Hojjat-Farsangi

Vahid Karpisheh

Farhad Jadidi-Niaragh

2023/3/15

Establishment of a murine model of breast cancer expressing human epidermal growth factor receptor 2 (4T1-HER2)

Journal of Cancer Research and Therapeutics

Vahid Khaki Bakhtiarvand

Khadijeh Ramezani-Ali Akbari

Fatemeh Sadri

Farzaneh Notash Haghighat

Mohammad Hojjat-Farsangi

...

2023/7/19

IGF1R and HIF-1α Gene Silencing Inhibits Cancer Cell Growth

International Journal of Drug Research in Clinics

Shiva Abolhasani

Sepideh Javadi

Hadi Hassannia

Ghasem Ghalamfarsa

Mohammad Hojjat-Farsangi

...

2023/11/7

The prognostic and therapeutic potential of HO-1 in leukemia and MDS

Mohammad Sadeghi

Mehrdad Fathi

Jamshid Gholizadeh Navashenaq

Hamed Mohammadi

Mehdi Yousefi

...

2023/3/13

Application of emerging plant-derived nanoparticles as a novel approach for nano-drug delivery systems

Immunological investigations

Parisa Sarvarian

Parisa Samadi

Elham Gholipour

Karim Shams Asenjan

Mohammad Hojjat-Farsangi

...

2022/5/19

See List of Professors in Mohammad hojjat-farsangi University(Karolinska Institutet)

Co-Authors

H-index: 76
Qiang Pan-Hammarström

Qiang Pan-Hammarström

Karolinska Institutet

H-index: 65
Mehdi Yousefi

Mehdi Yousefi

Tabriz University of Medical Sciences

H-index: 42
fazel shokri

fazel shokri

Tehran University of Medical Sciences

H-index: 39
Keivan Zandi

Keivan Zandi

Universiti Malaya

H-index: 30
Rahim Tahmasebi

Rahim Tahmasebi

Bushehr University of Medical Sciences

H-index: 30
Tohid Kazemi

Tohid Kazemi

Tabriz University of Medical Sciences

academic-engine